429 related articles for article (PubMed ID: 6305492)
1. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
2. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
Ioannou YM; Wilson AG; Anderson MW
Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
[TBL] [Abstract][Full Text] [Related]
3. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
Anderson MW; Boroujerdi M; Wilson AG
Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
[TBL] [Abstract][Full Text] [Related]
4. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
5. Effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene by mouse lung microsomes.
Sydor W; Lewis KF; Yang CS
Cancer Res; 1984 Jan; 44(1):134-8. PubMed ID: 6317167
[TBL] [Abstract][Full Text] [Related]
6. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by aryl hydrocarbon hydroxylase inducers.
Wilson AG; Kung HC; Boroujerd M; Anderson MW
Cancer Res; 1981 Sep; 41(9 Pt 1):3453-60. PubMed ID: 6266656
[TBL] [Abstract][Full Text] [Related]
7. Alterations in microsomal metabolism of benzo[a]pyrene in mice fed butylated hydroxyanisole.
Speier JL; Wattenberg LW
J Natl Cancer Inst; 1975 Aug; 55(2):469-72. PubMed ID: 1159828
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitous binding of benzo[a]pyrene metabolites to DNA and protein in tissues of the mouse and rabbit.
Stowers SJ; Anderson MW
Chem Biol Interact; 1984 Sep; 51(2):151-66. PubMed ID: 6088095
[TBL] [Abstract][Full Text] [Related]
9. Neoplastic effects of oral administration of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and their inhibition by butylated hydroxyanisole.
Wattenberg LW; Jerina DM; Lam LK; Yagi H
J Natl Cancer Inst; 1979 Apr; 62(4):1103-6. PubMed ID: 285284
[TBL] [Abstract][Full Text] [Related]
10. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
[TBL] [Abstract][Full Text] [Related]
11. Modifications of microsomal and nuclear fractions by butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules.
Demkowicz-Dobrzański KK; Hennig EE; Juśkiewicz-Skiba M; Piekarski L
Neoplasma; 1984; 31(4):423-30. PubMed ID: 6089009
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin and indomethacin on the formation of benzo(a)pyrene-induced pulmonary adenomas and DNA adducts in A/HeJ mice.
Adriaenssens PI; Sivarajah K; Boorman GA; Eling TE; Anderson MW
Cancer Res; 1983 Oct; 43(10):4762-7. PubMed ID: 6309376
[TBL] [Abstract][Full Text] [Related]
13. Benzo(a)pyrene metabolism and metabolites binding to DNA in the presence of BHA.
Sawicki J; Selkirk JK; Kugaczewska M; Piekarski L; McLeod MC
Arch Geschwulstforsch; 1980; 50(4):317-21. PubMed ID: 7458578
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits.
Horton JK; Rosenior JC; Bend JR; Anderson MW
Cancer Res; 1985 Aug; 45(8):3477-81. PubMed ID: 3926299
[TBL] [Abstract][Full Text] [Related]
15. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
Nakayama J; Yuspa SH; Poirier MC
Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid.
Dixit R; Teel RW; Daniel FB; Stoner GD
Cancer Res; 1985 Jul; 45(7):2951-6. PubMed ID: 4039974
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of the antioxidant butylated hydroxyanisole on the activation of the carcinogen benzo(a)pyrene.
Piekarski L; Sawicki J; Kugaczewska M; Potocki LJ; Sankowski A; Uszyński H; Małunowicz E; Wojciechowska M; Kolodziejska A; Fox CH
Neoplasma; 1979; 26(2):139-44. PubMed ID: 471121
[TBL] [Abstract][Full Text] [Related]
18. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo.
Pelling JC; Slaga TJ; DiGiovanni J
Cancer Res; 1984 Mar; 44(3):1081-6. PubMed ID: 6198079
[TBL] [Abstract][Full Text] [Related]
19. Effects of 2- and 3-tert-butyl-4-hydroxyanisole on glutathione S-transferase and epoxide hydrolase activities and sulfhydryl levels in liver and forestomach of mice.
Lam LK; Sparnins VL; Hochalter JB; Wattenberg LW
Cancer Res; 1981 Oct; 41(10):3940-3. PubMed ID: 7285002
[TBL] [Abstract][Full Text] [Related]
20. Wide-range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice.
Dunn BP
Cancer Res; 1983 Jun; 43(6):2654-8. PubMed ID: 6303565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
